INTRODUCTION
Increasing evidence indicates that mitochondria (Mt) are intimately associated with initiation of programmed cell death (PCD) in neurons (see Ref. 1 for review) and that Mt membrane depolarization (MMD) is associated with induction of reactive oxygen species (ROS) and initiation of PCD. Cells use free radical scavengers to detoxify superoxide and hydroxyl radicals and thereby prevent cellular injury due to oxidative stress. Detoxification of H 2 O 2 occurs primarily in the Mt, where it is reduced by glutathione. Reduction of H 2 O 2 generates an oxidized glutathione disulfide that, in turn, must be reduced by NADPH to regenerate glutathione. With hyperglycemia, glucose flux generates sorbitol, which is converted to fructose and depletes the NADPH needed for regenerating glutathione, thus resulting in Mt dysfunction. 2 Increased metabolic flux in the Mt due to high glucose results in increased formation of ROS such as superoxides, peroxinitrites, and highly reactive hydroxyl radicals. 3 These ROS are associated with membrane lipid peroxidation, nitration of proteins (including tyrosine residues), and degradation of DNA, all of which are associated with induction of apoptosis. 4 In neurons, accumulation of NADH coupled with failure of the Mt creatine phosphate pump to regenerate ATP from ADP also results in disruption of the Mt electron transfer chain and depletion of ATP associated with apoptosis. 1 Although ROS has been associated with animal models of diabetes, it is unclear if oxidative stress is also important in human diabetic neuropathy. Further, the mechanisms linking oxidative stress to PCD and ultimately dorsal root ganglion (DRG) neuronal and Schwann cell (SC) loss in diabetic neuropathy are essentially unknown and will be discussed below.
METHODS

Dissociated embryonic DRGs from
Harlan Sprague-Dawley rats were aseptically plated on air-dried, collagen-coated ACLAR dishes in the presence of serum-and insulin-free media and 10 ng/mL nerve growth factor (NGF) as previously described. 5, 6 SH-SY5Y human neuroblastoma cells were grown in DMEM with 10% calf serum at 37°C in a humidified atmosphere containing 10% CO 2 as previously described. 7 In experiments, cells were subcultured in DMEM alone with the experimental condition. SC were cultured as previously described. 8 SH-SY5Y neurons and SC do not normally require NGF for survival.
To obtain tissue samples, animals were perfused prior to death with Trump's fixative (4% paraformaldehyde and 1% glutaraldehyde in 0.1 M phosphate buffer) by intracardiac infusion. 6 The whole vertebral column was removed and a 4-to 5-mm strip of bone was excised from the dorsal roof of the vertebral column as previously described. 6 In cell culture, neurons were fixed for 15 min in 4% paraformaldehyde. Human sural nerve biopsies were obtained from four subjects with moderately severe diabetic neuropathy or from four subjects of similar age after traumatic amputation (two) or with connective tissue disease and sensory symptoms (two) as previously described. 9 To detect caspase-3 staining, DRG neurons or tissue sections (10 µm) were stained with 0.1 µg/mL CM1 antibody (kindly provided by A. Srinivasan, IDUN Pharm, La Jolla, CA) and 7.5 µg/mL rhodamine-conjugated goat anti-rabbit antibody (Vector, Burlingame, CA) for 1 h as previously described. 6, 10 The nuclear chromatin was counterstained with 1 µg/mL bisbenzamide in PBS. Neurons were considered to have active caspase-3 if staining could be clearly localized to the neuronal or SC cytosol on sequential sections using both DIC and immunofluorescence. To determine if staining is specific for cleaved caspase-3, the antibody was preimmunoabsorbed with peptide in sections 10 to indicate cleaved (active) caspase-3.
TdT-mediated dUTP-biotin nick end labeling (TUNEL) staining was used to detect apoptotic neurons. For staining of apoptotic nuclei in cell cultures, cells are grown on ACLAR dishes and fixed in 4% paraformaldehyde. Samples are labeled with digoxigenin-dUTP and then stained with FITC-conjugated antidigoxigenin antibody as previously described. 6 Transmission electron microscopy (TEM) of DRG neurons and SC was performed as previously described. 5, 6 A caspase-3 fluorometric assay kit (Pharmingen, San Diego, CA) was used to determine caspase-3 activation in SH-SY5Y neurons and SC. The assay was conducted according to the manufacturer's instructions and in conjunction with an Epics Elite flow cell sorting (FACS-Coulter Cytometry, Hialeah, FL) using excitation at 380 nm and emission at 440 nm. 8 All experiments were conducted with the following controls: cell lysate alone, Ac-DEVD-AMC alone, nonapoptotic cells, and positive apoptotic controls. Caspase cleavage was gated in live cells with propidium iodide (PI) exclusion (18 µg/mL). The mean of the peak caspase-3 level and the percent of neurons expressing cleaved caspase-3 were measured. Changes in the Mt membrane potential (∆Ψ M ) in SC were determined by incubating with 5 µg/mL rhodamine 123 (Rh123) for 30 min at 37°C followed by FACS. Alternatively, DRGs were incubated in 2.5 mg/mL JC-1 for 30 min at 37°C, and 590:530 ratios were measured using a fluorometer (Fluoroskan Ascent, Labsystems, Helsinki, Finland) and confirmed by confocal microscopy.
Adenovirus (Ad) constructs for uncoupling protein-1 (UCP1) and green fluorescent protein (GFP) were purified in the University of Iowa Viral Core. For DRG neurons, we obtained a 95-100% infection rate at 24 h with an MOI of 1000. Adenoviral constructs showed no intrinsic toxicity to DRG neurons. NGF p75 receptor function blocking antibody (p75NTR FBA) was kindly provided by Louis Reichardt (University of California, San Francisco).
Immunoblotting for caspase-9 was performed in lysates of whole 12-month streptozotocin (STZ) diabetic rat nerves (kindly provided by Douglas Zochodne, University of Calgary) with caspase-9 Ab (Santa Cruz, CA) at 1:1000 for 2 h. The secondary antibody was a horseradish peroxidase conjugate, applied for 1 hour, and visualized with enhanced chemiluminescence reagents (Amersham, MA). 8 
RESULTS
Hyperglycemia Is Associated with Oxidative Stress in Diabetic Neuropathy Models
In human neuronal (SH-SY5Y) cells exposed to high glucose, there is an increase in ROS generation that peaks at 2-3 h (FIG. 1) and then declines corresponding to increased cell death. 11 Increased ROS generation is associated with Mt depolarization and enlargement. 11 Swelling of Mt has been confirmed in STZ diabetic and acutely hyperglycemic rats, where the DRG neurons contain ballooned Mt with disrupted cristae. 6 Although, at very high magnification, lysosomal integrity is maintained, frequent large vacuoles measuring from 0.25 to 1 µm in diameter are observed evenly distributed throughout the cytoplasm. 6 At high magnification, these vacuoles are seen to occur in Mt that are ballooned and have disruption of the inner cristae structure. Although occasional vacuolization is observed in DRG cells from control animals, the Mt structure appears normal.
In human SC, there is also clear evidence of Mt enlargement and disruption of the normal cristae structure (FIG. 2) . Whereas SC from nondiabetic subjects have normal Mt and rough endoplasmic reticulum, those from subjects with moderately severe diabetic neuropathy show formation of frequent vacuoles of variable size ranging up to 300 nm in diameter. While many of the vacuoles lack specific organellar structure, several enlarged Mt with still visible cristae structures are observed (FIG. 2C) , consistent with increased oxidative damage to the Mt structure.
Hyperglycemia Results in Mt Swelling and Dysregulation of the Inner Mt Membrane Potential
Based on the findings of induction of oxidative stress and Mt damage in the peripheral nervous system (PNS), we next looked at the changes in the Mt membrane potential in neurons and SC. In DRG neurons exposed to increased concentrations of glucose, there is an initial hyperpolarization (more negative ∆Ψ M ) followed by depolarization (less negative ∆Ψ M ), as seen in FIGURE 3A. DRG neurons were treated with 20 mM added glucose for a period of 6 h, and changes in the ∆Ψ M were measured using the potentiometric dye, JC-1. JC-1 exists as an aggregate at very negative membrane potentials (∆Ψ M < −100 mV) with a red fluorescence at 590 nm, and as a monomer with green fluorescence at 530 nm with less negative potentials (∆Ψ M > FIGURE 1. Glucose induces production of ROS in SH-SY5Y human neurons. SH-SY5Y neurons were cultured up to 24 h in control serum-free media ± 20 mM added glucose, treated with 2 µM CM-H 2 DCFDA, and analyzed with FACS to determine changes in oxidative stress. Experiments were standardized against control values at 0 h. With addition of 20 mM added glucose, there was an initial threefold increase in the mean relative DCF fluorescence that peaked at 2 h ( P < 0.0001) and then declined, corresponding to increased neuronal death. Plotted values represent the mean relative DCF fluorescence as a percent of control at 0 h (100%) ± SEM. Data were obtained from three separate experiments.
−100 mV). Equal numbers of neurons were used at each time point and the ratio was standardized against protein levels. There was an increase in the 590:530 ratio with glucose exposure from 15 min to 3-6 h, followed by a decline in the ratio consistent with depolarization, which persists to at least 24 h. With valinomycin or oligomycin There is initial hyperpolarization on exposure to glucose followed by depolarization starting between 3 and 6 h. Complete depolarization is observed with valinomycin or oligomycin controls. (B) SC were cultured for 24 h with increasing glucose, followed by FACS analysis with Rh123. The data were plotted as a percent of the corresponding control value at the same time point. Even with 20 mM added glucose, the ∆Ψ M was significantly reduced compared to control after 24 h (P < 0.0001).
(not shown), complete depolarization was observed. Similar results are obtained using Rh123 and TMRM, although evidence of depolarization is usually observed by 6 h using these cell-permeant dyes (data not shown). TMRM has the advantage of reducing fluorescent quenching sometimes observed with JC-1. In SC exposed to high concentrations of glucose, there is a dose-dependent decline in the ∆Ψ M consistent with MMD. With 20 mM added glucose, the mean Rh123 measured using FACS decreased to 20% of control (P < 0.001), with almost complete loss of the ∆Ψ M with 300 mM glucose (FIG. 3B) .
Hyperglycemia Is Associated with PCD in Diabetic Neuropathy Models and Human Disease
Recent observations from our own and other laboratories indicate that apoptosis is one of the underlying causes of diabetic neuropathy. 6, 8, [12] [13] [14] Clear pathological changes of apoptosis occur in DRG neurons and SC in STZ-treated diabetic rats. 6, 8 Hyperglycemia induces caspase-3 cleavage in DRG cultures and a significant number of neurons are TUNEL-positive in STZ-treated rats after 1 month of hyperglycemia, indicating extensive and regular DNA fragmentation associated with apoptosis. The percent of apoptotic neurons in diabetic animals closely correlates with the serum glucose levels (R 2 > 0.9), indicating that hyperglycemia is a likely trigger for apoptosis. In addition to the Mt dysfunction and apoptosis, our previously published data demonstrate a loss of neurons in rats after 3 months of diabetes. Using counting corrections for split nuclei, we estimated that the DRG number was 164 ± 16 in STZ diabetic animals, and 128 ± 19 in control animals, with a reduction in mean DRG area from 1110.3 ± 81.2 in control animals to 906.8 ± 51.3 µm 2 in diabetics. 6 In tissue from C57BL/6 mice made acutely hyperglycemic with slow peritoneal infusion of 50% dextrose (mean serum glucose = 311.2 ± 13.4 mg/dL, n = 5) and control animals (mean serum glucose = 161.8 ± 7.3 mg/dL, n = 5), there is an increase in caspase-3 staining in DRG and, to a lesser extent, in SC (FIG. 4) . Animals were sacrificed 24 h after attaining maximal hyperglycemia. Cytosolic caspase-3 cleavage was coupled with evidence of nuclear chromatin condensation, although this was a less sensitive measure of neuronal injury. In addition to cleavage of caspase-3 in both neurons and SC, 8 there is also evidence of caspase-9 cleavage in nerves from 12-month STZ diabetic rats. Although minimal cleavage of caspases is observed in most tissue that is removed from live animals and processed, there was a 40% increase in caspase-9 cleavage in sural nerve from the diabetic animals (FIG. 4E) .
Changes in animal models of diabetes are reproduced in human SC (FIG. 5) . Compared to normal human SC with diffuse chromatin staining, there is increased chromatin condensation (FIG. 5B) , with shrinkage of the SC cytosol. Eventually, there is loss of the SC nucleus and cytosol with preservation of the plasma membrane and supporting collagen, forming ghost cells. These changes are consistent with single cell deletion observed in apoptosis, but rarely in necrosis. No inflammatory infiltrates were observed in the affected nerves, such as might be seen with necrosis of the peripheral nerve. The white arrow indicates chromatin condensation in a Schwann cell. (E) Caspase-9 cleavage is increased in chronic diabetic rat nerve. Immunoblotting of whole 12-month STZ diabetic rat nerves for caspase-9 showed a 40% increase in the 37-kDa cleavage product, using densitometry, compared to control. There is diffuse chromatin staining in the nucleus (black arrow), an intact perikaryon and basal lamina (black arrowheads), and myelinated axon.
(B) SC from a subject with diabetic neuropathy. There is chromatin condensation in the nucleus with cytoplasmic shrinkage (black arrowheads). (C) Two SC from a subject with diabetic neuropathy, showing loss of normal cytoplasm and nuclear structure. In one SC only, the plasma membrane remains, forming a ghost (black arrowheads).
Regulation of Glucose-induced Oxidative Stress and Mt Membrane Potential Inhibits PCD
Glucose oxidation in the Mt increases the supply of electrons to the electron transfer chain, leading to increased proton pumping from the Mt and resulting in initial hyperpolarization of the ∆Ψ M . Ultimately, increased electron loss from the electron transfer chain induces formation of superoxide anions and other ROS. This can be blocked by treatment with electron transfer inhibitors such as myxothiazole. In neurons cultured under control conditions, a reduction in electron transfer along the chain by myxothiazole would lead to a reduction in the ∆Ψ M . Myxothiazole inhibits the Mt respiratory chain at cytochrome b-c 1 . 15 In control neurons, addition of 3 µM myxothiazole results in mild depolarization, whereas it maintains the ∆Ψ M , which is usually decreased, in the presence of high glucose (FIG. 6) . In Mt treated with high glucose that are biochemically compromised, oligomycin induces rapid depolarization consistent with Mt dependence on ATP synthase (data not shown). In high glucose states, myxothiazole is able to regulate generation of superoxides and prevent MMD. Coupled with this, myxothiazole blocks an increase in the mean level of caspase-3 cleavage and in the percentage of caspase-3-positive neurons (FIG. 6) .
A further approach to regulating the ∆Ψ M in the presence of high glucose is with growth factors. Growth factors such as NGF may also serve as antioxidants and this function may contribute to their role as possible therapeutic entities in diabetic neuropathy. [16] [17] [18] At 24 h, exposure to increased glucose results in MMD that is blocked by a physiological concentration of NGF (FIG. 7) . By contrast, pretreatment with 50 µg/mL p75NTR FBA blocks the effect of NGF on the ∆Ψ M . These results indicate that NGF mediates some of its Mt stabilizing effects through the p75NTR. High glucose induces dose-dependent cleavage of caspases in SC (FIG. 8) . SC were cultured for 6 h in increasing glucose, and caspase-3 cleavage was measured. Caspase-3 cleavage was increased by 6 h with 20-50 mM glucose and blocked by 10 ng/mL NGF or the caspase-3 inhibitor, DEVD-CHO. A similar inhibition of apoptosis, measured with TUNEL, was seen with 10 ng/mL NGF, but was reversed by pretreatment with p75NTR FBA (FIG. 8B) . These results show that NGF inhibits SC apoptosis through the p75NTR.
The UCPs are inner Mt membrane proteins that can dissipate the protonelectrochemical gradient; that is, they uncouple Mt electron transfer from oxidative phosphorylation. 19 UCPs share considerable amino acid sequence homology to one another, suggesting that they all possess an uncoupling function. However, the UCPs also have frequent homology to Mt transporters, as well as displaying typical Mt energy transfer protein signatures, suggesting that they may be Mt carriers. 20, 21 This function will help regulate the ∆Ψ M with hyperglycemic Mt injury and will prevent initial hyperpolarization. UCP1 is a classical UCP that is not normally expressed in neurons. In the presence of 20 mM added glucose, there is an increase in cleavage of caspase-3 and TUNEL-positive DRG neurons (FIG. 9) . Cleavage of caspases is blocked at 6 h by overexpression of UCP1 (FIG. 9) , and induction of apoptosis is blocked at 24 h (P < 0.001).
DISCUSSION
Recent evidence suggests that oxidative stress is responsible for the development and progression of neuropathy. 22 Blocking oxidative stress in the diabetic animal prevents the development of neuropathy 22 and restores sciatic and saphenous nerve FIGURE 7. NGF prevents MMD in SC exposed to high glucose using FACS. The mean Rh123 level is decreased at 24 h, in the presence of high glucose, but maintained by addition of a physiological concentration of NGF (10 ng/mL). NGF inhibition of MMD is blocked by 50 µg/mL p75NTR FBA.
conduction velocities in STZ diabetic rats. 23, 24 Our data indicate that increased concentrations of glucose rapidly induce production of ROS. This can be modulated by reducing electron flux along the electron transfer chain and generation of superoxide anions using myxothiazole. In turn, myxothiazole is able to reduce MMD seen with high glucose and to block induction of caspase cleavage. This most likely results from the ability of myxothiazole to reduce generation of ROS and to stabilize the ∆Ψ M .
In DRG and SC exposed to high glucose, both in vivo and in vitro, there is Mt swelling and ultimately a decrease in the ∆Ψ M , an event that in other paradigms initiates PCD. 1 It has previously been shown that release of cytochrome c into the FIGURE 8. NGF inhibition of glucose-induced apoptosis is blocked by p75NTR FBA. (A) Cleavage of caspase-3 is increased in SC exposed to high glucose in a dose-dependent fashion. The percent of SC with cleavage of caspase-3 was determined at 6 h using increasing concentrations of glucose ± 10 ng/mL NGF or DEVD-CHO, and is expressed as a log scale. (B) Apoptosis in SC is inhibited by addition of NGF. SC apoptosis was determined at 24 h using PI and FACS analysis. Treatment with 50 µg/mL p75NTR FBA blocked NGF neuroprotection. *P < 0.05, **P < 0.01, ***P < 0.001 compared to control.
cytosol is associated with formation of a cytochrome c/caspase-9/Apaf-1 complex (the apoptosome) and cleavage of downstream effector caspases such as caspase-3 and caspase-7. 1 In human and rat neurons, hyperglycemia induces Mt dysfunction and apoptosis, 6, 14 and similar changes are observed in another important cell in the PNS-namely, the SC. In nerve from 12-month diabetic rats, there is an increase in caspase-9 cleavage, and caspase-3 cleavage is seen in cultured SC exposed to high glucose. Similar to changes in rat neurons, human SC show evidence of both Mt swelling and apoptosis.
Impaired trophic support, such as reduced NGF levels seen in diabetic neuropathy, results in increased peroxinitrite formation and cleavage of caspases. 17 By contrast, we show that administration of NGF regulates MMD and blocks PCD. NGF may prevent PCD by blocking cell death signaling through the p75NTR 25 and by upregulating PCD threshold proteins such as Bcl-xL and Bcl-2. 17, 26 While chronic diabetes in humans may be associated with down-regulation of UCPs, up-regulation of UCP1 is clearly mediated through increased expression of p85α-phosphatidylinositol 3-kinase (PI-3K) or mitogen-activated protein kinase (MAPK)/MAPextracellular signal-regulated kinase (MEK). These signal transduction molecules are critical intermediates of several growth factors including NGF and insulin-like growth factor (IGF-I). 27, 28 Growth factor regulation of the ∆Ψ M by UCPs, especially UCP2 and UCP3, expressed in DRG neurons, 29 would reduce generation of ROS and prevent induction of PCD, and ultimately may ameliorate diabetic neuropathy.
CONCLUSIONS
These observations in the PNS have led to our proposing the following model for regulation of glucose-induced oxidative stress and PCD in neuropathy. Glucose induction of ROS is critical to the pathogenesis of diabetic neuropathy. Loss of electrons from the Mt electron transfer chain, coupled with initial hyperpolarization of the ∆Ψ M , results in generation of excess ROS in the Mt. In turn, there is increased Mt injury, MMD, and swelling with release of apoptosis-inducing factors from the Mt into the cytosol, leading to formation of an apoptosome. Growth factors upregulate UCPs in the Mt and Bcl PCD threshold proteins like Bcl-2/Bcl-xL, stabilize the ∆Ψ M , and block formation of ROS and induction of PCD. Further understanding of these mechanisms will be useful in developing potential therapeutic strategies in diabetic neuropathy.
